[ Price : $8.95]
FDA accepts a BeiGene supplemental NDA for Brukinsa (zanubrutinib) in combination with obinutuzumab for treating adult patients wi...[ Price : $8.95]
Federal Register notice: FDA announces a 9/11-12 Nonprescription Drugs Advisory Committee meeting to discuss decongestant phenylep...[ Price : $8.95]
ADC Therapeutics pauses new patient enrollment in the Phase 2 LOTIS-9 clinical trial evaluating Zynlonta (loncastuximab tesirine-l...[ Price : $8.95]
Three stakeholders praise an FDA guidance on adding clinical outcome assessments to patient-focused drug development regulatory de...[ Price : $8.95]
Megadyne recalls its MEGA 2000 and MEGA SOFT Reusable Patient Return Electrodes after receiving burn reports affecting pediatric a...[ Price : $8.95]
Two stakeholders respond positively to a recent FDA workshop on innovative drug manufacturing techniques.[ Price : $8.95]
FDA says it no longer sees the potential for excess mortality in paclitaxel-coated devices used to treat peripheral arterial disea...[ Price : $8.95]
FDA publishes a draft guidance recommending how to optimize and standardize dietary management in clinical trials of drugs to trea...